News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
493,213 Results
Type
Article (51528)
Company Profile (91)
Press Release (441594)
Multimedia
Podcasts (37)
Webinars (10)
Section
Business (133749)
Career Advice (994)
Deals (19744)
Drug Delivery (73)
Drug Development (61278)
Employer Resources (81)
FDA (13569)
Job Trends (10713)
News (233196)
Policy (22814)
Tag
Academia (2862)
Academic (1)
Accelerated approval (4)
Adcomms (15)
Allergies (82)
Alliances (34355)
ALS (72)
Alzheimer's disease (1101)
Antibody-drug conjugate (ADC) (70)
Approvals (13598)
Artificial intelligence (196)
Autoimmune disease (11)
Automation (9)
Bankruptcy (165)
Best Places to Work (8539)
BIOSECURE Act (7)
Biosimilars (50)
Biotechnology (64)
Bladder cancer (68)
Brain cancer (23)
Breast cancer (229)
Cancer (1796)
Cardiovascular disease (143)
Career advice (844)
Career pathing (19)
CAR-T (108)
Cell therapy (296)
Cervical cancer (17)
Clinical research (50599)
Collaboration (569)
Compensation (140)
Complete response letters (12)
COVID-19 (2244)
CRISPR (24)
C-suite (213)
Cystic fibrosis (70)
Data (1858)
Decentralized trials (2)
Denatured (22)
Depression (35)
Diabetes (201)
Diagnostics (4617)
Digital health (14)
Diversity (9)
Diversity, equity & inclusion (25)
Drug discovery (75)
Drug pricing (81)
Drug shortages (21)
Duchenne muscular dystrophy (70)
Earnings (42843)
Editorial (30)
Employer branding (10)
Employer resources (71)
Events (65779)
Executive appointments (650)
FDA (14647)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (524)
Gene editing (70)
Generative AI (11)
Gene therapy (208)
GLP-1 (494)
Government (3752)
Grass and pollen (3)
Guidances (45)
Healthcare (15238)
Huntington's disease (12)
IgA nephropathy (21)
Immunology and inflammation (52)
Indications (23)
Infectious disease (2358)
Inflammatory bowel disease (98)
Inflation Reduction Act (7)
Influenza (45)
Intellectual property (64)
Interviews (123)
IPO (8300)
IRA (34)
Job creations (2489)
Job search strategy (780)
Kidney cancer (8)
Labor market (17)
Layoffs (238)
Leadership (5)
Legal (4416)
Liver cancer (65)
Lung cancer (262)
Lymphoma (126)
Machine learning (4)
Management (24)
Manufacturing (175)
MASH (57)
Medical device (13482)
Medtech (13486)
Mergers & acquisitions (11791)
Metabolic disorders (501)
Multiple sclerosis (64)
NASH (13)
Neurodegenerative disease (69)
Neuropsychiatric disorders (15)
Neuroscience (1516)
NextGen: Class of 2025 (5305)
Non-profit (3950)
Now hiring (17)
Obesity (247)
Opinion (97)
Ovarian cancer (68)
Pain (73)
Pancreatic cancer (68)
Parkinson's disease (110)
Partnered (13)
Patents (153)
Patient recruitment (98)
Peanut (44)
People (47734)
Pharmaceutical (23)
Pharmacy benefit managers (11)
Phase I (15215)
Phase II (22255)
Phase III (16998)
Pipeline (834)
Policy (99)
Postmarket research (2136)
Preclinical (5822)
Press Release (43)
Prostate cancer (87)
Psychedelics (20)
Radiopharmaceuticals (190)
Rare diseases (265)
Real estate (4555)
Recruiting (31)
Regulatory (16346)
Reports (20)
Research institute (2266)
Resumes & cover letters (129)
Rett syndrome (3)
RNA editing (2)
RSV (31)
Schizophrenia (58)
Series A (87)
Series B (60)
Service/supplier (5)
Sickle cell disease (46)
Special edition (3)
Spinal muscular atrophy (118)
Sponsored (21)
Startups (2750)
Stomach cancer (10)
Supply chain (48)
Tariffs (17)
The Weekly (14)
Vaccines (566)
Venture capitalists (17)
Weight loss (162)
Women's health (23)
Worklife (7)
Date
Today (75)
Last 7 days (582)
Last 30 days (1783)
Last 365 days (22699)
2025 (7287)
2024 (24315)
2023 (28035)
2022 (37404)
2021 (40385)
2020 (39626)
2019 (35996)
2018 (27421)
2017 (23706)
2016 (23487)
2015 (27340)
2014 (21126)
2013 (18820)
2012 (20091)
2011 (20056)
2010 (18163)
Location
Africa (535)
Alabama (27)
Alaska (5)
Arizona (147)
Arkansas (11)
Asia (30905)
Australia (5351)
California (3872)
Canada (1407)
China (419)
Colorado (198)
Connecticut (202)
Delaware (129)
Europe (64825)
Florida (654)
Georgia (169)
Idaho (42)
Illinois (439)
India (19)
Indiana (257)
Iowa (4)
Japan (133)
Kansas (78)
Kentucky (20)
Louisiana (9)
Maine (33)
Maryland (714)
Massachusetts (2718)
Michigan (144)
Minnesota (299)
Mississippi (2)
Missouri (57)
Montana (29)
Nebraska (19)
Nevada (41)
New Hampshire (66)
New Jersey (1284)
New Mexico (19)
New York (1218)
North Carolina (722)
North Dakota (5)
Northern California (1661)
Ohio (170)
Oklahoma (12)
Oregon (27)
Pennsylvania (998)
Puerto Rico (10)
Rhode Island (29)
South America (754)
South Carolina (22)
Southern California (1491)
Tennessee (93)
Texas (649)
United States (15799)
Utah (135)
Virginia (106)
Washington D.C. (50)
Washington State (331)
West Virginia (3)
Wisconsin (45)
493,213 Results for "erasmus university medical center".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Erasmus Medical Center Safety Committee Grants Approval to Proceed with Phase 2 Study of Ampligen® and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
February 5, 2025
·
4 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Drug Development
AIM ImmunoTech Receives Erasmus Medical Center Ethics Board Authorization for Phase 2 Study of Ampligen® for the Treatment of Locally Advanced Pancreatic Cancer
AIM ImmunoTech Inc. today announced that it has received authorization from the Erasmus Medical Center (“Erasmus MC”) Ethics Committee to open a European site for the ongoing Phase 2 study (“AMP-270”) of Ampligen as a therapy for locally advanced pancreatic cancer.
January 24, 2024
·
2 min read
Press Releases
Cagent Vascular Initiates Patient Enrollment in the Serranator® vs. POBA OCT Study at Columbia University Medical Center
April 10, 2025
·
2 min read
Press Releases
Pramana to Enable Vanderbilt University Medical Center’s Pathology Digitization Efforts, Advancing Clinical Care and AI-Driven Research
January 22, 2025
·
2 min read
Press Releases
Leading Cardiologist & Echocardiographer Appointed Medical Director of NYU Langone’s Aortic Center
April 10, 2025
·
4 min read
Press Releases
Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht
February 10, 2025
·
14 min read
Business
QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center
QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.
June 24, 2024
·
5 min read
Press Releases
GT Medical Technologies Announces Launch of GammaTile® Center of Excellence Program and First Designation, USC Brain Tumor Center
April 9, 2025
·
3 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
1 of 49,322
Next
